Daré Bioscience and Rosy Wellness Launch First Phase of Patient-Focused Campaign to Support DARE to PLAY™ Sildenafil CreamGlobeNewsWire • 07/29/25
UPDATE - Daré Bioscience to Host August 6 Webinar: The DARE to PLAY™ Difference - The Sildenafil Cream That Raises the BarGlobeNewsWire • 07/21/25
Daré Bioscience Receives $6 Million Non-Dilutive Grant Installment; $37.8M to Date of up to $49M Commitment Supporting Smart Drug Delivery Device for Contraception; Platform has Broader Application Potential in Obesity and Metabolic DisordersGlobeNewsWire • 07/11/25
Dare Bioscience, Inc. (DARE) Reports Q1 Loss, Lags Revenue EstimatesZacks Investment Research • 05/13/25
Daré Bioscience Reports First Quarter 2025 Financial Results and Provides Company UpdateGlobeNewsWire • 05/13/25
Dare Bioscience, Inc. (DARE) Reports Q4 Loss, Misses Revenue EstimatesZacks Investment Research • 03/31/25
Daré Bioscience Reports Full Year 2024 Financial Results and Provides Company UpdateGlobeNewsWire • 03/31/25
Daré Bioscience to Host Full Year 2024 Financial Results and Company Update Conference Call and Webcast on March 31, 2025GlobeNewsWire • 03/24/25
Daré Bioscience Announces Funding Award Notice from the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Support DARE-HPV DevelopmentGlobeNewsWire • 02/06/25
Daré Bioscience to Participate in the Women's Health Series at the 43rd Annual J.P. Morgan Healthcare ConferenceGlobeNewsWire • 01/09/25
Daré Bioscience Reports Third Quarter 2024 Financial Results and Provides Company UpdateGlobeNewsWire • 11/14/24
Dare Bioscience (DARE) Upgraded to Buy: Here's What You Should KnowZacks Investment Research • 11/07/24
Daré Bioscience to Host Third Quarter 2024 Financial Results and Company Update Conference Call and Webcast on November 14, 2024GlobeNewsWire • 11/07/24
Daré Bioscience Selected to Receive $10 Million Award from ARPA-H's Sprint for Women's HealthGlobeNewsWire • 10/23/24
Daré Bioscience Announces Common Stock Purchase Agreement for up to $15 Million with Lincoln Park Capital Fund, LLCGlobeNewsWire • 10/21/24
Daré Bioscience Reports Second Quarter 2024 Financial Results and Provides Company UpdateGlobeNewsWire • 08/12/24
Biotech Executive Lisa Walters-Hoffert Joins Kiora Pharmaceuticals' Board of DirectorsNewsfile Corp • 07/01/24